Business Intelligence
Spending was driven by increases in drug unit prices rather than an increase in the volume of drugs used, report says.
Companies will work together to develop and deploy new population health offerings by tapping each company's expertise and assets.
Health system started the first phase of its modernization project that CEO Kenneth Davis said will transform how it delivers care services.
Partner Fund Management was a major investor in Theranos, backing it with a $96.1 million investment in 2014.
Payer, pharma giant are collaborating in a value-based agreement for the type 2 diabetes medications Januvia and Janumet.
About 10 million Americans buy individual coverage on or off the marketplaces, get no federal subsidies to help lower cost, feds say.
New law, which takes effect Jan. 1, will address mental health care gaps, particularly in rural areas where recruiting, retaining providers is hard.
Even with an estimated 25 percent premium increase, 78 percent of marketplace consumers should be able to find plan for $100 per month or less.
FDA approved drug Exondys 51 made by Sarepta Therapeutics to treat Duchenne muscular dystrophy.
Massive settlement with DOJ allows EpiPen maker to avoid admitting wrongdoing in how it has classified the emergency allergy treatment since 2007.